| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/14651858.CD007630.PUB2 |
| P8608 | Fatcat ID | release_ekq2vy6uifcszmimfgkx2o2mwy |
| P3181 | OpenCitations bibliographic resource ID | 4359132 |
| P698 | PubMed publication ID | 22161415 |
| P5875 | ResearchGate publication ID | 51871107 |
| P50 | author | Catey Bunce | Q28039205 |
| P2093 | author name string | Kostas G Boboridis | |
| P2860 | cites work | Orbital radiotherapy for adult thyroid eye disease | Q24241938 |
| An individualized approach to orbital decompression in Graves' orbitopathy | Q69802470 | ||
| Transantral orbital decompression for malignant exophthalmos | Q74570750 | ||
| Is orbital decompression a safe and effective treatment for Graves' orbitopathy? | Q80854529 | ||
| The incidence of diplopia following coronal and translid orbital decompression in Graves' orbitopathy | Q33539731 | ||
| Epidemiology and prevention of Graves' ophthalmopathy | Q34165523 | ||
| Immunosuppressive therapy in patients with thyroid eye disease: an overview of current concepts | Q34199530 | ||
| Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: the GO-QOL. | Q35305938 | ||
| Reversal of dysthyroid optic neuropathy following orbital fat decompression | Q35315008 | ||
| Effects of Graves' ophthalmopathy on quality of life | Q35785147 | ||
| Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards | Q36728722 | ||
| Advances in surgical rehabilitation in thyroid eye disease | Q40054472 | ||
| Thyroid-associated ophthalmopathy: pathogenesis and clinical management. | Q40511567 | ||
| Outcome of orbital decompression for disfiguring proptosis in patients with Graves' orbitopathy using various surgical procedures | Q46083146 | ||
| Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial | Q46665485 | ||
| Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. | Q50933902 | ||
| Transconjunctival fat removal combined with conservative medial wall/floor orbital decompression for Graves orbitopathy. | Q53353546 | ||
| A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves' ophthalmopathy. | Q53359335 | ||
| The removal of the deep lateral wall in orbital decompression: its contribution to exophthalmos reduction and influence on consecutive diplopia. | Q53571441 | ||
| Balanced orbital decompression combined with fat removal in Graves ophthalmopathy: do we really need to remove the third wall? | Q53656516 | ||
| Modification of the Classification of the Eye Changes of Graves' Disease: Recommendations of the Ad Hoc Committee of The American Thyroid Association | Q67020629 | ||
| Endoscopic transnasal orbital decompression | Q68714491 | ||
| The pathogenesis of Graves' ophthalmopathy | Q68947222 | ||
| Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy | Q69288448 | ||
| P921 | main subject | eye disease | Q3041498 |
| P577 | publication date | 2011-12-07 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Surgical orbital decompression for thyroid eye disease |
| Q36348372 | A review of Cochrane systematic reviews of interventions relevant to orthoptic practice |
| Q37106626 | Clinical efficacy of combined rituximab treatment in a woman with severe Graves' ophthalmopathy |
| Q42433372 | Computer-Assisted Three-Dimensional Planning for Orbital Decompression |
| Q26800562 | Critical Appraisal on Orbital Decompression for Thyroid Eye Disease: A Systematic Review and Literature Search |
| Q55001461 | Cutting-edge endonasal surgical approaches to thyroid ophthalmopathy. |
| Q61797316 | Development of a core outcome set for amblyopia, strabismus and ocular motility disorders: a review to identify outcome measures |
| Q38207885 | Fat-removal orbital decompression for disfiguring proptosis associated with Graves' ophthalmopathy: safety, efficacy and predictability of outcomes |
| Q47399634 | Geriatric patients are predisposed to strabismus following thyroid-related orbital decompression surgery: A multivariate analysis |
| Q92983927 | Influence of orbital morphology on proptosis reduction and ocular motility after decompression surgery in patients with Graves' orbitopathy |
| Q60332531 | Magnetic resonance imaging with diffusion-weighted imaging in the evaluation of thyroid-associated orbitopathy: getting below the tip of the iceberg |
| Q53101493 | Optical coherence tomography measurements in compressive optic neuropathy associated with dysthyroid orbitopathy. |
| Q39159003 | Orbital Decompression for Thyroid Eye Disease |
| Q49829361 | Orbital decompression for thyroid eye disease: methods, outcomes, and complications. |
| Q37026793 | Orbital decompression surgery and horse chestnut seed extract improved superior orbital vein blood flow in patients with thyroid-associated ophthalmopathy |
| Q52606254 | Original endoscopic orbital decompression of lateral wall through hairline approach for Graves' ophthalmopathy: an innovation of balanced orbital decompression. |
| Q92679767 | Practice Patterns in Orbital Decompression Surgery Among American Society of Ophthalmic Plastic and Reconstructive Surgery Members |
| Q49946639 | Rehabilitative orbital decompression for Graves' orbitopathy: results of a randomized clinical trial. |
| Q35843225 | Results after En Bloc Lateral Wall Decompression Surgery with Orbital Fat Resection in 111 Patients with Graves' Orbitopathy |
| Q24202845 | Rituximab for thyroid-associated ophthalmopathy |
| Q38979463 | Surgical complications in orbital decompression for Graves' orbitopathy. |
| Q40790395 | Thyroid-Related Orbital Decompression Surgery: A Multivariate Analysis of Risk Factors and Outcomes |
| Q93333216 | Tocilizumab for thyroid eye disease |
| Q94355143 | Tocilizumab for thyroid eye disease |
| Q54325672 | [Orbital decompression : Indications, technique, results]. |
Search more.